Illumina Presses $113.3M Bid For DNA Sequencer
Illumina Inc., the gene-sequencing company that successfully fended off a hostile takeover earlier this year from pharmaceutical giant Roche AG, is now involved in a battle of its own after biotech...To view the full article, register now.
Already a subscriber? Click here to view full article